Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1996
12/19/1996WO1996040264A1 Separation of active complexes
12/19/1996WO1996040263A2 Semicarbazide-containing linker compounds for formation of stably-linked conjugates and methods related thereto
12/19/1996WO1996040262A2 Process for preparing encapsulated water soluble beta-carotene
12/19/1996WO1996040261A1 Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
12/19/1996WO1996040260A2 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996WO1996040259A2 Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
12/19/1996WO1996040251A1 Prevention and treatment of sepsis
12/19/1996WO1996040245A1 Improved delivery of diagnostic and therapeutic agents to a target site
12/19/1996WO1996040225A1 Immunogenic and immunostimulatory oligosaccharide compositions and methods of making and using them
12/19/1996WO1996040221A1 Wound healing formulations containing human plasma fibronectin
12/19/1996WO1996040217A1 Thrombopoietin compositions
12/19/1996WO1996040194A1 Stable formulations of mhc-peptide complexes
12/19/1996WO1996040192A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds
12/19/1996WO1996040171A1 Intrauterine chemical necrosing method and composition
12/19/1996WO1996040168A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device
12/19/1996WO1996040163A1 Purified galactomannan as an improved pharmaceutical excipient
12/19/1996WO1996040144A1 Oral acyclovir delivery
12/19/1996WO1996040139A1 Novel formulations for transdermal delivery of pergolide
12/19/1996WO1996040123A1 Antigen-processing cell-targeted conjugates
12/19/1996WO1996040090A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
12/19/1996WO1996040089A2 Aerosol drug formulations containing vegetable oils
12/19/1996WO1996040086A2 Compositions and methods for topical administration of pharmaceutically active agents
12/19/1996WO1996040085A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
12/19/1996WO1996040084A1 Compositions and methods for use of pressure sensitive adhesive transdermal devices containing a bioadhesive humectant
12/19/1996WO1996040082A2 Apparatus and method for delivering a biologically active compound into a biological environment
12/19/1996WO1996040078A1 Delivery of drugs to the lower gi tract
12/19/1996WO1996040075A1 Large scale production process with instantaneous component mixing and controlled sequential mixing characteristics
12/19/1996WO1996040074A2 Device for releasing aggregation-stabilized, biologically active agent
12/19/1996WO1996040073A2 Composition for sustained release of non-aggregated erythropoietin
12/19/1996WO1996040072A2 Composition for sustained release of human growth hormone
12/19/1996WO1996040058A2 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
12/19/1996WO1996040056A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996WO1996040055A2 Biological agent compositions
12/19/1996WO1996040049A1 Peptide/protein suspended formulations
12/19/1996WO1996040047A1 Alpha hydroxyacid esters for skin aging
12/19/1996WO1996040042A2 Stabilized steroid compositions
12/19/1996WO1996039995A1 High viscosity liquid controlled delivery system
12/19/1996WO1996039870A1 Fat substitutes containing water soluble beta-caroten
12/19/1996WO1996039835A1 Method of solubilizing and encapsulating itraconazole
12/19/1996WO1996033744A3 Compositions in glassy phase, stabilised by a sugar
12/19/1996DE19521684A1 Ophthalmic pharmaceutical composition
12/19/1996CA2451973A1 Method of increasing the solubility of tissue factor pathway inhibitor
12/19/1996CA2451970A1 Method to aid refolding of tissue factor pathway inhibitor
12/19/1996CA2451969A1 Method of purifying tissue factor pathway inhibitor
12/19/1996CA2450953A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450804A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450800A1 Method of solubilizing, purifying, and refolding protein
12/19/1996CA2450797A1 Method of solubilizing proteins containing two oppositely-charged domains
12/19/1996CA2450795A1 Method of refolding tissue factor pathway inhibitor
12/19/1996CA2236946A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996CA2228998A1 Prevention and treatment of sepsis
12/19/1996CA2224230A1 Oral acyclovir delivery
12/19/1996CA2224227A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds
12/19/1996CA2224170A1 Delivery of drugs to the lower gi tract
12/19/1996CA2224162A1 Purified galactomannan as an improved pharmaceutical excipient
12/19/1996CA2223934A1 Separation of active complexes
12/19/1996CA2223928A1 Cationic lipid:dna complexes for gene targeting
12/19/1996CA2223923A1 Cationic lipid:dna complexes for gene targeting
12/19/1996CA2223921A1 Stabilization of polynucleotide complexes
12/19/1996CA2223834A1 Composition for sustained release of non-aggregated erythropoietin
12/19/1996CA2223832A1 Method for the treatment of corticosteroid induced osteopenia
12/19/1996CA2223605A1 Stable formulations of mhc-peptide complexes
12/19/1996CA2223590A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
12/19/1996CA2223583A1 Device for releasing aggregation-stabilized, biologically active agent
12/19/1996CA2223446A1 Thrombopoietin compositions
12/19/1996CA2223436A1 Composition for sustained release of human growth hormone
12/19/1996CA2223385A1 Stabilized steroid compositions
12/19/1996CA2223329A1 Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
12/19/1996CA2223324A1 Alpha hydroxyacid esters for skin aging
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2223179A1 Phosphonic acid-based cationic lipids
12/19/1996CA2222776A1 Biological agent compositions
12/19/1996CA2222595A1 Therapeutic microdevices and methods of making and using same
12/19/1996CA2222550A1 Nucleic acid transporters for delivery of nucleic acids into a cell
12/19/1996CA2222538A1 Apparatus and method for delivering a biologically active compound into a biological environment
12/19/1996CA2222247A1 Immunotoxins specific for cd80 and cd86 expressing cells
12/19/1996CA2221965A1 Liquid fluorocarbon emulsion as a vascular nitric oxide reservoir
12/19/1996CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996CA2221263A1 Novel formulations for transdermal delivery of pergolide
12/19/1996CA2218541A1 Novel targeted compositions for diagnostic and therapeutic use
12/19/1996CA2197244A1 Wound healing formulations containing human plasma fibronectin
12/18/1996EP0748633A2 Adhesive tissue and its use as haemostyptic
12/18/1996EP0748628A2 Oral formulations of S(+)-Etodolac
12/18/1996EP0748383A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences
12/18/1996EP0748377A1 IMPROVED DNase LIQUID SOLUTIONS
12/18/1996EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained
12/18/1996EP0748342A1 Block and graft copolymers and methods relating thereto
12/18/1996EP0748332A1 New cholesterol derivative for liposomal gene transfer
12/18/1996EP0748226A1 Block copolymers
12/18/1996EP0748218A1 Plaster-shaped transdermal system with a tamoxifen derivative
12/18/1996EP0748215A1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
12/18/1996EP0748213A1 Methods and compositions for pulmonary delivery of insulin
12/18/1996EP0748212A1 Oral vehicle compositions
12/18/1996EP0748208A1 Cosmetic and/or pharmaceutical preparations
12/18/1996EP0748203A1 LOW pH, HYDROLYTICALLY STABLE, COSMETIC COMPOSITIONS CONTAINING ACIDIC ACTIVES
12/18/1996EP0666736B1 Stabilization of fluorocarbon emulsions
12/18/1996CN1138318A Polyol composition produced by CO-spray-drying
12/18/1996CN1138298A Vaccines
12/18/1996CN1138296A Use of dimeticone for treating constipation
12/17/1996US5585499 Drug delivery
1 ... 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 ... 1712